Shocking Study Shows Chemotherapy Reactivates Dormant Cancer Cells – Triggers Metasis

(Note: Thank you for supporting businesses like the one presenting a sponsored message below and working with them through the links below which benefits Gateway Pundit. We appreciate your support!)

Nicholas Hulscher, MPH, writing at Dr. Peter McCullough’s Substack, breaks the results of a shocking new study:

Chemotherapy is supposed to kill cancer — not bring it back. But a groundbreaking Cancer Cell study by He et al has revealed that common cancer drugs like doxorubicin and cisplatin can reawaken dormant tumor cells, triggering deadly metastatic relapses — especially in the lungs.

These “sleeping” cancer cells, known as disseminated tumor cells (DTCs), can lie hidden for years before reactivating. This study is the first to directly prove that chemotherapy itself can wake them up.

This new study reveals five key findings:

1. Chemotherapy Reactivates Dormant Cancer Cells

   • Using DormTracer, the team showed that chemo-treated mice had a surge of previously dormant cancer cells re-entering the cell cycle.

   • These reawakened cells formed aggressive lung metastases weeks after chemo — even in cases where the primary tumor was gone.

   • This effect was specific todormant cells; chemo suppressed active tumors but inadvertently activated the sleeping ones.

2. Neutrophil Extracellular Traps (NETs) Are the Trigger

   • Chemotherapy didn’t just hit cancer cells — it also causedfibroblasts in the lungto enter a state called senescence (biological aging).

   • These senescent cells released pro-inflammatory signals that activated neutrophils — a type of white blood cell.

   • The neutrophils formedNETs — sticky webs of DNA and enzymes like MMP9 and neutrophil elastase — which remodeled the lung microenvironment and directly triggered dormant DTCs to awaken.

3. SASP Proteins (C3, MIF, CXCL1) Drive This Chain Reaction

   • The senescent fibroblasts released a toxic cocktail known as SASP (senescence-associated secretory phenotype).

   • Three key factors —Complement C3, Macrophage Migration Inhibitory Factor (MIF), and CXCL1 — were identified as major drivers of NET formation.

   • Mice engineered to lack C3 had far less NET activity and lower rates of metastasis after chemo.

4. Blocking NETs or Clearing Senescent Cells Prevents Relapse

   • AdministeringDNase I (which breaks up NETs) or GSK484 (a PAD4 inhibitor that blocks NET formation) completely prevented chemo-triggered metastasis in mice.

   • GivingDasatinib + Quercetin (a senolytic combo) cleared out the senescent fibroblasts and shut down the entire cascade — resulting in both primary tumor control and no relapse.

   • Importantly, this combination didn’t reduce chemo’s effectiveness at shrinking the primary tumor.

5. The Mechanism Was Confirmed in Humans

   • In breast cancer patients, lung metastases had higher NET density and elevated C3, MIF, and CXCL1 levels after chemotherapy.

   • Blood samples showed C3 and MIF spiked after treatment — especially in patients who later developed lung relapse.

   • These markers could becomepredictive biomarkers for relapse risk in future screening.

Hulscher concludes that:

This study flips the script on conventional cancer therapy. Chemotherapy may control the primary tumor — but it can also fuel future metastasis by waking up hidden cancer cells through inflammation and immune activation. Pairing chemo with senolytics or NET-blockers could dramatically reduce relapse — and early trials are already underway.

However, it’s time to explore cancer treatments that don’t harm the entire body and reawaken dormant cancer cells, such as:  IVERMECTIN.

A Promising New Treatment

This groundbreaking study should be the beginning of a rush by the medical establishment to look for alternatives to chemotherapy. Unfortunately, chemotherapy is big business for big pharma and the the medical establishment has absolutely no interest in pursuing effective and low-cost treatments.

Fortunately, medical professionals like Dr. Peter McCullough are committed to delivering healthcare solutions that are safe, effective AND affordable. This is exactly why Dr. McCullough and his team are digging in to the potential for ivermectin in combatting cancers.

According to a new study, the early returns are promising. According to the McCullough Foundation:

The study titled “A Review of Ivermectin Use in Cancer Patients: Is it Time to Repurpose the Ivermectin in Cancer Treatment?” was just published in the journal Acta Poloniae Pharmaceutica – Drug Research…

Based on the most comprehensive systematic review of ivermectin use in cancer patients to date, ivermectin appears to be safe—even in individuals undergoing active chemotherapy. Its broad range of anticancer mechanisms demonstrated in preclinical models, combined with anecdotal reports of cancer-related improvements, support its candidacy for repurposing as an oncologic therapy. Well-designed, large-scale clinical trials should be launched as soon as possible to properly assess ivermectin’s potential against cancer.

Indeed, ivermectin in concert with mebendazole has shown even more promise in treating a wide variety of cancers.

Mebendazole, an anti-parasitic like ivermectin, has been prescribed for 100 years to help eradicate parasites – which over 60 million Americans have inside their body today, according to the CDC.

Medication You Can Trust from a Trusted Source

The medical experts at The Wellness Company – like Dr. Peter McCullough and Dr. Kelly Victory – were leaders in the efforts to provide the public with accurate medical information during COVID. These experts have repeatedly shown that they prioritized the health and welfare of their patients over the bottom line of the big pharmaceutical companies.

Now, The Wellness Company is the only company in the world to prescribe compounded Ivermectin + Mebendazole, in a high-dose 90-day supply:

Ivermectin – Backed by science and honored with a Nobel Prize, Ivermectin delivers precise treatment against parasitic infections, ensuring effective care and well-being for your family with trusted precision.

Mebendazole – Trusted by healthcare professionals, Mebendazole targets and eliminates intestinal parasites with precision, ensuring your family’s health and well-being with proven efficacy and safety.

Head over to The Wellness Company today to order a 90-day supply of the ultimate parasite cleanse – Ivermectin + Mebendazole. Simply fill out the 2-minute intake questionnaire after checkout to complete your prescription request.

What people are saying about The Wellness Company’s Ivermectin + Mebendazole:

I am grateful to have a medicine as potentially beneficial as ivermectin and mebendazole, but the most important thing for me is the faith I have in Dr. McCullough and The Wellness Company for making a safe product, in our country. I am grateful for them protecting us through the use of proven products and the peace in knowing that I’m taking something that is precisely what it states on the labels. – Jennifer W.

My daughter was diagnosed with uterine cancer and lung nodules that turned out to be cancerous. She started taking ivermectin/mebendazole 2 weeks ago. She had a PET scan last month and her lungs were littered with dime and pea sized nodules from the top to the bottom of her lungs. She had a biopsy on the 14th of April and the Physcian had to SEARCH for a nodule big enough to get a sample from, and the ONE that he found was at the bottom of her left lung that he said was only a few centimeters wide…. Thank All of you Doctors on this site for giving us HOPE and HEALING!!! – Helen

Click here to order Ivermectin and Mebendazole from The Wellness Company today.

Note: The information provided on this website is intended for informational purposes only and should not be considered medical advice or used as a substitute for professional healthcare guidance. It is your responsibility to comply with all applicable laws, regulations, and guidelines regarding the purchase, possession, and use of prescription medications.